Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Stocks
Aarti Pharmalabs Ltd.
Swot
Aarti Pharmalabs Ltd. SWOT Analysis: Strengths, Weakness, Opportunity, and Threats
Aarti Pharmalabs Ltd. has 15 Strengths, 9 Weaknesses, 2 Opportunities and 1 Threats. The SWOT product gives you a quick x-ray of a stock's outlook and potential
Add SWOT widget to your site/app
Strengths
(15)
Weakness
(9)
Opportunity
(2)
Threats
(1)
Others
(2)
Stock passes majority of CANSLIM Investment criteria
Mid-range Performer (DVM)
Stocks seeing month price declines, good financial durability, and newly affordable valuations (subscription)
Company with high TTM EPS Growth
PEG lower than Industry PEG
High Momentum Scores (Technical Scores greater than 50)
Growth in Net Profit with increasing Profit Margin (QoQ)
Growth in Quarterly Net Profit with increasing Profit Margin (YoY)
Company with Low Debt
Annual Net Profits improving for last 2 years
Company with Zero Promoter Pledge
Near 52 Week High
Negative to Positive growth in Sales and Profit with Strong Price momentum
Volume Shockers
Stocks Outperforming their Industry Price Change in the Quarter
Promoter decreasing their shareholding
MACD Crossover Below Signal Line
Stocks in downtrend most likely to cross below SMA-200 soon
Decline in Quarterly Net Profit (YoY)
High volume, top losers
RSI indicating price weakness
MACD crossed below signal line previous end of day
Biggest Price Losers from Open
Top Losers
Buys by Superstar Investors
FII / FPI or Institutions increasing their shareholding
MFs decreased their shareholding last quarter
Average Affordability - Stocks with Medium Trendlyne Valuation Score versus Benchmarks
Average Bullish Trend - Stocks with Medium Trendlyne Momentum Score versus Benchmarks
